Steven B Ketchum

CIK 1289884 · EVP, Chief Scientific Officer · last filed 2026-02-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$623.0K

Companies

3

Total Filings

87

Lifetime Open-Market Net

-$24.75M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMRN EVP, Chief Scientific Officer 40,879 $15.24 $623.0K -$24.80M 69 2026-02-03
Viracta Therapeutics, Inc. (SNSS) Delisted Director 86,378 $18.62 $1.61M $43.5K 17 2020-07-01
Viracta Therapeutics, Inc. (SNSSD) Delisted Sr. Vice President, R & D 72,921 $0 1 2011-03-02

Recent Filings · Page 3 of 9

87 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-01-04 AMRN Mixed +23,334 -$81.9K EDGAR
2021-09-02 AMRN Mixed +2,981 -$17.3K EDGAR
2021-08-04 AMRN Grant (A) $0 EDGAR
2021-08-03 AMRN Mixed +2,981 -$12.9K EDGAR
2021-07-02 AMRN Mixed +2,981 -$14.0K EDGAR
2021-05-28 AMRN Mixed +2,984 -$14.2K EDGAR
2021-04-30 AMRN Mixed +2,984 -$16.4K EDGAR
2021-04-02 AMRN Mixed +2,984 -$19.9K EDGAR
2021-03-01 AMRN Mixed +54,250 -$408.3K EDGAR
2021-02-03 AMRN Mixed −25,370 -$1.27M EDGAR
Showing 2130 of 87
Page 3 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.